Cargando…
A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening
Accurate patient-derived models of cancer are needed for profiling the disease and for testing therapeutics. These models must not only be accurate, but also suitable for high-throughput screening and analysis. Here we compare two derivative cancer models, microtumors and spheroids, to the gold stan...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678976/ https://www.ncbi.nlm.nih.gov/pubmed/31336733 http://dx.doi.org/10.3390/cells8070702 |